Global Cell Cycle Analysis
Market Overview
The Cell
Cycle Analysis Market Insights by Product,
End-User– Global Forecast Till 2030
Cell cycle analysis refers to a method that
uses flow cytometry to differentiate cells in different phases of the cell
cycle. Cells are generally permeabilized before the analysis and treated with a
fluorescent dye which stains the DNA quantitatively. Cell cycle analysis products
have several applications in life science research activities, biomedical
research, and clinical research laboratories. The global cell cycle analysis
market is expected to upscale at an impressive CAGR during the forecast period.
Various factors which are listed in the
report published by MRFR that are driving the global cell cycle analysis market
include an increased expenditure on cell level research by the corporate sector
and various government initiatives undertaken by the government to support the
same. On the other hand, the rising prevalence of chronic genetic diseases and
disorders has led to ascension in demand for solutions, pushing the cell cycle
analysis market. Further, a mounting occurrence of cell-specific diseases and
cancer is fueling sizeable growth in the global cell cycle analysis market over
the review period.
Moreover, prominent players in the global
cell cycle analysis market are adopting aggressive expansion strategies, which
are likely to influence the market growth positively over the assessment
period. For instance, in March 2018, Agilent technologies acquired advanced
analytical technologies for USD 250 million. The prime purpose of this
acquisition was to develop a unique product portfolio to fuel the competitive
edge that the market giant held over its peers.
However, some factors are expected to pose
as hindrances in the growth of the global cell cycle analysis market. A high
cost of cell cycle analysis instruments and higher economies of scale are some
of the factors hampering growth in the market over the review period.
Market
Segmentation
The global cell cycle analysis market has
been studied for various segments to enable a detailed and precise study of the
market during the forecast period. Such segmentation has been carried out on
the basis of product, application, end-user, and region. Based on product, the
cell cycle analysis market is segmented into consumables and instruments. The
consumables segment is further sub-segmented into reagents, microplates, assay
kits, and other consumables. The assay kits segment includes the sub-segments
of immunoassays and cell-based assays. The instruments segment is sub-segmented
into flow cytometry, microscopes, qPCR, cell counter, spectrophotometer, high
content screening systems, and cell microarrays.
Based on application, the global cell cycle analysis market trends is segmented into cell
viability, cell identification, cell proliferation, cell counting & quality
control, cell signaling pathway/signal transduction, cell interaction, target
identification, cell structure study, and validation & single-cell
analysis. Based on end-users, the global cell cycle analysis market is
segmented into hospitals & diagnostic laboratories, academics &
research institutions, and pharmaceuticals.
Key Players
Some of the key players to be noted in the
global cell cycle analysis market include Becton, Merck & Co., Inc. (U.S.),
Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE
Healthcare (UK), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.),
PerkinElmer, Inc. (U.S.), Olympus Corporation (Japan), Promega Corporation
(U.S.), Miltenyi Biotech (Germany), Bio-Rad Laboratories, Inc. (U.S.), and
Nexcelom Bioscience LLC. (U.S.).
Detailed Regional
Analysis
The global cell cycle analysis market is
regionally segmented into the Americas, Europe, Asia Pacific, and the Middle
East & Africa. The Americas are further sub-segmented into North America
and South America. The Americas are anticipated to head the global cell cycle
analysis market over the forecast period. This market dominion can be
attributed to the presence of many well-established research and development
facilities, rising prevalence of cancer, and government funding to encourage
cell level research and development.
Europe is expected to trail behind the
Americas and capture the second-largest share in the cell cycle analysis
market. This can be attributed to the adoption of highly advanced technology.
Furthermore, a mounting number of life sciences and medical research institutes
in Europe is noted to push the regional cell cycle analysis market.
Asia Pacific is projected to ascend at the
highest rate in the global cell cycle analysis market due to magnified
investments in life sciences and favorable policies introduced by the
government. On the other hand, the Middle East & Africa are likely to
account for the smallest share in the market owing to an underdeveloped
healthcare and research sector and the lack of technical knowledge.
Industry Update
February 2019: A research conducted by the
Department of Pathology and Cancer Research Center from Yanbian University
Medical College inferred that the presence of HSDL2 protein was significantly
higher in breast cancer tissues as compared to normal breast tissues. This was
significantly associated with higher histological grades, low survival rates,
and late clinical stages.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment